Granisetron Transdermal Patch and Phenelzine: Interaction Details
- Phenelzine
- Nardil
- Granisetron Transdermal Patch
- SancusoSustolGranisol
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Granisetron Transdermal Patch and Phenelzine interaction:
Granisetron Transdermal Patch
- Sancuso
- Sustol
- Granisol
What Happens When You Take Granisetron Transdermal Patch With Phenelzine
What can happen when they are taken together (rated Contraindicated)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Phenelzine, an , should not be given together with drugs, because doing so raises the risk of serotonin syndrome. A gap of at least 14 days is needed when switching in either direction, that is, after stopping phenelzine before starting a serotonergic drug, or after stopping a serotonergic drug before starting phenelzine.
FLUoxetine is the exception to this rule. When phenelzine is to be started after a serotonergic drug, enough time must pass for that drug and its active to be cleared.1
Where cannot be avoided, patients should be observed for signs and symptoms of serotonin syndrome. The condition can be life-threatening. Should it occur, the agents responsible must be stopped, and supportive care and any other needed treatment should be given.3
The Granisetron Transdermal Patch and Phenelzine Interaction, Explained
Phenelzine (Nardil) is an used for depression. Granisetron patches (Sancuso) help prevent nausea from chemotherapy. Both can raise in the body, so together they can push serotonin too high. This is called . Signs include agitation, sweating, shaking, fast heartbeat, diarrhea, and fever. It can be serious.
This pairing is listed as , meaning it should normally be avoided. Please don't stop or start either medicine on your own. Tell your pharmacist and doctor about both so they can plan safe timing or choose another option for nausea.
Interaction: Phenelzine (irreversible nonselective ) plus granisetron (5-HT3 , transdermal) carries an increased risk of via (). Evidence: probable. Onset: unspecified. per labeling.
- Neither agent's effect is altered by activation; this is additive PD toxicity, not a PK change.
- Allow at least 14 days between stopping phenelzine and starting a serotonergic drug, or vice versa (fluoxetine excepted). Allow adequate of granisetron before starting phenelzine.
- If is unavoidable, monitor for serotonin syndrome (neuromuscular excitability, autonomic instability, altered mental status).
- If it occurs, discontinue offending agents and provide supportive care.
See the 6 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Granisetron Transdermal Patch and Phenelzine Interact
The likely mechanism
How to Manage the Granisetron Transdermal Patch and Phenelzine Interaction
The documented approach is to avoid using these two medicines together.
- Your care team will usually leave at least 14 days between stopping one and starting the other.
- If you are starting phenelzine after granisetron, they will allow enough time for the granisetron to clear your body.
- If both are truly needed, your team may monitor you more closely for signs of .
Tell your pharmacist and prescriber about every medicine you take, including patches. Seek urgent care if you develop agitation, tremor, sweating, fever, or a racing heart. Don't change either medicine without talking to your care team.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Granisetron Transdermal Patch or Phenelzine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
3 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: NARDIL oral film coated tablets, phenelzine sulfate oral film coated tablets
Serious reactions, including hyperthermia, rigidity, myoclonic movements and death, have been reported when serotoninergic drugs (eg, dexfenfluramine, FLUoxetine, fluvoxaMINE, PARoxetine, sertraline, citalopram, venlafaxine) were given together with an .1
-
Report 2 · Study title
Case scenario: opioid association with serotonin syndrome: implications to the practitioners
FentaNYL is a synthetic piperidine with proserotonergic activity, and it has been linked to when given with other drugs such as . Where possible, serotonergic opioids (eg, fentaNYL) may be replaced with non-serotonergic opioids (eg, morphine).2
When cannot be avoided, patients should be monitored for symptoms of serotonin syndrome. Serotonin syndrome may be life-threatening. If it develops, the offending agents should be discontinued and supportive care and other therapy provided as needed.3
-
Report 3 · Study title
Danger of MAOI therapy after fluoxetine withdrawal (letter)
The interaction between St. John's Wort and rests on evidence that combining with may lead to .4 In theory, using St. John's Wort together with a monoamine oxidase inhibitor () could result in serotonin syndrome.
St. John's Wort has mild MAOI properties, which could add to the adverse effects of the MAOI and possibly cause toxicity (), although this has never been reported clinically. The importance of any monoamine oxidase by St. John's Wort is controversial, though constituents of the herb have shown mild monoamine oxidase inhibitory effects.56
Granisetron Transdermal Patch and Phenelzine: Common Questions
How serious is the Granisetron Transdermal Patch and Phenelzine interaction?
It is rated . These should generally not be used together.
How is the Granisetron Transdermal Patch and Phenelzine interaction managed?
The documented approach is to avoid using these two medicines together. Your care team will usually leave at least 14 days between stopping one and starting the other. If you are starting phenelzine after granisetron, they will allow enough time for the granisetron to clear your body. If both are truly needed, your team may monitor you more closely for signs of . Tell your pharma… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Granisetron Transdermal Patch and Phenelzine Interaction
Ask in your own words about taking Granisetron Transdermal Patch and Phenelzine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (6)
- Product Information: NARDIL(R) oral film coated tablets, phenelzine sulfate oral film coated tablets. Parke-Davis Div of Pfizer Inc (per DailyMed), New York, NY, 2020. DailyMed
- Rastogi R, Swarm RA, & Patel TA: Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011; 115(6):1291-1298. PubMed
- Boyer EW & Shannon M: The serotonin syndrome. N Eng J Med 2005; 352(11):1112-1120. DOI
- Sternbach H: Danger of MAOI therapy after fluoxetine withdrawal (letter). Lancet 1988; 2:850-851. PubMed
- Thiede HM & Walper A: Inhibition of MAO and COMT by hypericum extracts and hypericin. J Geriatr Psychiatry Neurol 1994; 7 (Suppl 1):S54-S56. DOI
- Demisch L, Holzl J, Gollnik B, et al: Identification of selective MAO Type A inhibitors in Hypericum perforatum L. (Hyperforat(R)). Pharmacopsychiatry 1989; 22:194.
Other Serious Interactions of Granisetron Transdermal Patch and Phenelzine
Also serious with Phenelzine
- Acetaminophen and CodeineContraindicated
- AmitriptylineContraindicated
- SertralineContraindicated
- BuprenorphineContraindicated
Also serious with Granisetron Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.